Demand for treatments for diseases such as cancer are in high demand, but identifying new drugs is an expensive and time-consuming process. CHARM Therapeutics leverages the power of deep learning for drug discovery.
CHARM Therapeutics is headed up by a team with impressive experience in the fields of AI and protein research. This expertise has garnered the company significant attention, culminating in a $50 million series A round in 2022 and a $20 million VC round the following year. This funding is a clear testament to the company's potential.
CHARM Therapeutics is one of a raft of new companies exploring the ways in which AI can transform drug discovery. However, it has set itself apart with its focus on small molecule treatments. This distinction will prove invaluable as the company looks to secure further funding.
Steph
Company Specialist at Welcome to the Jungle